HHV-6 associated diseases are one of the major factors on higher early CNS complications in CB recipients than in those of BM/PBSC
Bone Marrow Transplant
.
2021 Mar;56(3):686-688.
doi: 10.1038/s41409-020-01028-5.
Epub 2020 Aug 11.
Authors
Kosei Kageyama
1
,
Naoyuki Uchida
2
,
Hisashi Yamamoto
1
,
Shinsuke Takagi
1
,
Michiho Ebihara
1
,
Mitsuhiro Yuasa
1
,
Daisuke Kaji
1
,
Aya Nishida
1
,
Kazuya Ishiwata
3
,
Go Yamamoto
1
,
Yuki Asano-Mori
1
,
Koji Izutsu
1
,
Atsushi Wake
3
,
Akiko Yoneyama
4
,
Shigeyoshi Makino
5
,
Shuichi Taniguchi
1
Affiliations
1
Department of Hematology, Toranomon Hospital, Tokyo, Japan.
2
Department of Hematology, Toranomon Hospital, Tokyo, Japan. nuchida@toranomon.gr.jp.
3
Department of Hematology, Toranomon Hospital Kajigaya, Kanagawa, Japan.
4
Department of Infectious Diseases, Toranomon Hospital, Tokyo, Japan.
5
Department of Transfusion Medicine, Toranomon Hospital, Tokyo, Japan.
PMID:
32782352
DOI:
10.1038/s41409-020-01028-5
No abstract available
Publication types
Letter
MeSH terms
Bone Marrow Transplantation
Hematopoietic Stem Cell Transplantation* / adverse effects
Herpesvirus 6, Human*
Humans
Peripheral Blood Stem Cell Transplantation*